Industry Insights
Detecting Mutations With Liquid Biopsies
Industry InsightHere we summarize the webinar that was hosted by Monika Seidel Ph.D., in which she discussed detecting mutations with liquid biopsies in cancer diagnostics.
Read More
Meeting Renewed Regulatory Focus on Gene Therapy Safety Standards
Industry InsightIn this industry insights piece, we explore how gene therapies represent a rapidly growing new paradigm — both therapeutically and with respect to how they are managed within the larger scope of healthcare — and how this has wide-ranging impacts on several key areas, including regulation.
Read More
Eliciting the Hormetic Effect: The Importance of Plant Alkaloids for Treatment of Inflammation
Industry InsightToday, plant alkaloids are attracting notice as novel therapies for conditions involving inflammation, such as metabolic syndrome, autoimmune disease and even for aging, which are often characterized by chronic, low-grade over-activation of the immune system. This piece takes a closer look at the need for novel treatments and the best uses for plant alkaloids.
Read More
PCR: The "Workhorse" Technology
Industry InsightTechnology Networks spoke with Dr Jan Hellemans, CTO and co-founder of CRO Biogazelle, as well as co-author of the MIQE guidelines, to learn why PCR-based technologies are the "workhorse" technologies for the company.
Read More
A "One-and-Done" Treatment To Protect Against Heart Disease?
Industry InsightVerve Therapeutics is utilizing two of the biggest scientific breakthroughs of the twenty-first century – DNA sequencing and genome editing – to design a one-time treatment for lowering cholesterol.
Read More
The Impact of Emerging SARS-CoV-2 Variants on Diagnostic Testing
Industry InsightThe emergence of SARS-CoV-2 variants has led to concerns over the potential impacts there could be on the effectiveness of diagnostics and other countermeasures. Here, we look at the effects the B.1.1.7 variant may have on diagnostic tests.
Read More
Epigenetics Optimized Cell Culture Conditions To Drive and Maintain Cell Identity
Industry InsightTechnology Networks spoke with Pierre-Louis Joffrin, corporate development officer at Mogrify, to learn more about the EpiMOGRIFY platform, the advantages of using a data-driven method to maintain cell identity and support cell conversion, and the implications this could have for the development of cell therapies.
Read More
Staying Ahead of the Curve in the Californian Cannabis Testing Industry
Industry InsightTo find out more about cannabis testing in California and how CannaSafe is working hard to ensure consumers and patients receive contaminant-free and rigorously-tested cannabis, we spoke to their President, Aaron Riley.
Read More
3 Major Trends for Cardiac Drug Discovery in 2020
Industry InsightWithout a doubt, we will remember 2020 as the year of the COVID-19 pandemic. For the biopharma and healthcare sectors, the focus was firmly on the rapid development of diagnostics, therapies and vaccines that could be produced at scale. But under the radar, other life science fields have been powering on – among them, the cardiac field.
Read More
How Will Genome UK Securely Handle 150 Petabases of Genomic Data?
Industry InsightGenomic data company PetaGene recently sounded a warning that Genome UK, the UK government’s recently announced genomic healthcare strategy, needs to address important data handling challenges to maintain public trust. To find out more, Technology Networks spoke to PetaGene’s co-founder and chief commercial officer, Vaughan Wittorff, PhD, and co-founder and chief executive officer, Dan Greenfield, PhD.
Read More
